ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)

Import this data to Google Sheets with:

=jivedata("ARQT","financials")

Full statements spill as a table. For one cell: =jivedata("ARQT","Revenue") or =jivedata("ARQT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT • CIK 0001787306

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$59,606	$166,542	$372,072	$461,981
Revenue Not from Contract with Customer	—	$30,000	$4,000	$2,000
Revenues	—	$196,542	$376,072	$463,981
Operating Income (Loss)	$-241,101	$-128,397	$-12,227	$34,253
Income (Loss) Attributable to Parent, before Tax	$-259,027	$-139,392	$-14,970	$29,298
Income Tax Expense (Benefit)	$3,113	$647	$1,171	$779
Net Income (Loss) Attributable to Parent	$-262,140	$-140,039	$-16,141	$28,519
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-261,050	$-140,050	$-16,178	$27,898
Cost of Goods and Services Sold	$4,987	$19,128	$36,695	$41,096
Research and Development Expense	$110,575	$76,420	$77,051	$91,037
Selling, General and Administrative Expense	$185,145	$229,391	$274,553	$297,595
Costs and Expenses	$300,707	$324,939	$388,299	$429,728
Interest Income, Other	—	—	$8,897	$8,635
InterestExpenseNonoperating	—	$27,168	$12,083	$13,846
Other Nonoperating Income (Expense)	$11,786	$16,173	$443	$-4,560
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$1,186	$219	$-206	$-421
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$-96	$-230	$169	$-200
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	$1,090	$-11	$-37	$-621
Weighted Average Number of Shares Outstanding, Basic	69,305,487	120,957,633	127,234,000	130,663,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, Fair Value Disclosure	$88,398	$71,335	$42,907	$34,121
Restricted Cash and Cash Equivalents	$925	$617	$308	$308
Property, Plant and Equipment, Net	$1,539	$1,041	$1,043	$872
Debt Securities, Available-for-sale, Current	$183,463	$156,620	$178,075	$204,431
Intangible Assets, Net (Excluding Goodwill)	$6,438	$9,479	$14,812	$13,687
Accounts Receivable, after Allowance for Credit Loss, Current	$25,807	$73,066	$146,229	$155,162
Operating Lease, Right-of-Use Asset	$2,361	$1,953	$4,467	$4,253
Inventory, Net	$13,134	$14,526	$22,634	$38,879
Other Assets, Noncurrent	$596	$596	$1,419	$2,054
Prepaid Expense and Other Assets, Current	$18,704	$19,656	$21,079	$34,770
Assets	$341,365	$348,889	$432,973	$488,537
Assets, Current	$330,431	$335,820	$411,232	$467,671
Operating Lease, Liability, Noncurrent	$3,382	$2,562	$5,266	$5,237
Long-term Debt, Excluding Current Maturities	$201,799	$107,203	$107,959	$101,950
Other Liabilities, Noncurrent	$849	$570	$431	$431
Liabilities	$252,698	$191,348	$243,494	$267,958
Accounts Payable, Current	$11,992	$14,220	$12,528	$6,604
Long-term Debt, Current Maturities	—	—	$1,000	$6,950
Accrued Liabilities, Current	$33,941	$65,973	$116,310	$146,786
Liabilities, Current	$46,668	$81,013	$129,838	$160,340
Common Stock, Value, Issued	$9	$12	$12	$12
Additional Paid in Capital	$1,070,558	$1,279,479	$1,327,595	$1,355,593
Accumulated Other Comprehensive Income (Loss), Net of Tax	$4	$-7	$-44	$-656
Retained Earnings (Accumulated Deficit)	$-981,904	$-1,121,943	$-1,138,084	$-1,134,370
Stockholders' Equity Attributable to Parent	$88,667	$157,541	$189,479	$220,579
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	96,787,343	117,848,033	123,332,672	125,591,000
Inventory, Raw Materials, Net of Reserves	$9,951	$4,300	$5,047	$15,931
Inventory, Work in Process, Net of Reserves	$486	$584	$5,033	$8,781
Inventory, Finished Goods, Net of Reserves	$2,697	$9,642	$12,554	$14,167
Other Prepaid Expense, Current	$8,208	$8,199	$9,017	$15,210
Employee-related Liabilities, Current	$14,872	$20,747	$20,533	$15,507
Other Accrued Liabilities, Current	$3,299	$6,796	$17,044	$14,327

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-262,140	$-140,039	$-16,141	$28,519
Net Cash Provided by (Used in) Operating Activities	$-247,057	$-112,158	$-5,625	$39,309
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-50	$-235	$168	$-201
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$34,448	$-17,371	$-28,737	$-38,619
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$89,323	$71,952	$43,215	$24,564
Share-based Payment Arrangement, Noncash Expense	$38,813	$41,730	$40,364	$43,549
Payments to Acquire Debt Securities, Available-for-sale	$225,840	$254,820	$246,986	$285,468
Amortization of Intangible Assets	$750	$1,959	$4,667	$2,250
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	—	—	$227,419	$209,772
Paid-in-Kind Interest	—	$5,404	$1,756	$1,851
Payments to Acquire Property, Plant, and Equipment	$428	$143	$686	$158
Accretion (Amortization) of Discounts and Premiums, Investments	$6,989	$6,901	$2,094	$945
Payments to Acquire Intangible Assets	$0	$5,000	$10,000	$0
Other Noncash Income (Expense)	—	—	$-652	$-795
Net Cash Provided by (Used in) Investing Activities	$180,232	$28,820	$-30,253	$-85,982
Proceeds from Issuance of Common Stock	$0	$161,682	$0	$0
Repayments of Long-term Debt	—	$100,000	$0	$0
Proceeds from Stock Options Exercised	$1,247	$2,807	$4,597	$6,569
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$1,175	$1,713	$2,376	$2,686
Net Cash Provided by (Used in) Financing Activities	$101,323	$66,202	$6,973	$8,255
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	—	—	$2,858	$2,858
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$22,209	$10,327	$11,993
Increase (Decrease) in Accounts Receivable	$17,349	$47,259	$73,163	$48,476
Increase (Decrease) in Inventories	$5,620	$400	$7,329	$21,652
Increase (Decrease) in Prepaid Expense and Other Assets	$8,621	$948	$2,007	$17,299
Increase (Decrease) in Accounts Payable	$3,152	$2,229	$-1,694	$-8,480
Increase (Decrease) in Accrued Liabilities	$5,594	$32,033	$50,044	$59,749

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ARQT","financials")

Full statements spill as a table. For one cell: =jivedata("ARQT","Revenue") or =jivedata("ARQT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.